NDC codes

404917 NDC codes with hospital pricing data in the network.

• NDC 7632990610 — Epinephrine 1 mg/mL injectionAI (30 hospitals, 31–310 samples)
• NDC 9999910404 — Epinephrine IV drip in salineAI (20 hospitals, 31–310 samples)
• NDC 9999910832 — Epinephrine auto-injector (take-home)AI (20 hospitals, 31–310 samples)
• NDC 9999910833 — Epinephrine auto-injector 0.3 mg take-homeAI (20 hospitals, 31–310 samples)
• NDC 51672-5297-04 — PROMETHAZINE 25 MG RECTAL SUPPOSITORYAI (72 hospitals, 31–310 samples)
• NDC 59148-0232-12 — Aripiprazole extended-release injection, 300 mgAI (69 hospitals, 310 samples)
• NDC 63323-0262-36 — Heparin sodium 5,000 units per mL injectionAI (78 hospitals, 31–310 samples)
• NDC 67457-0153-00 — Amiodarone injection, 50 mg per mLAI (476 hospitals, 130–310 samples)
• NDC 00338-9632-01 — Piperacillin-tazobactam IV antibiotic infusionAI (52 hospitals, 31–310 samples)
• NDC 00409-1403-10 — Rocuronium bromide injection, 50 mg per 5 mL vialAI (130 hospitals, 112–310 samples)
• NDC 08888-8878-09 — Kit for preparing technetium-99m mebrofenin injectionAI (16 hospitals, 31–310 samples)
• NDC 31722-0041-32 — PROMETHAZINE 25 MG RECTAL SUPPOSITORYAI (26 hospitals, 31–310 samples)
• NDC 09991-2737-00 — Onabotulinumtoxin A injection, 20 units per mLAI (20 hospitals, 31–310 samples)
• NDC 61314-0318-10 — Zarxio 300 mcg/0.5 mL prefilled syringeAI (474 hospitals, 48–309 samples)
• NDC 00019-0862-09 — HIGH OSMOLAR CONTRAST MATERIAL, UP TO 149 MG/ML IODINE CONCENTRATION, PER ML (9 hospitals, 165–309 samples)
• NDC 57894-0061-03 — Ustekinumab 90 mg/mL prefilled syringeAI (561 hospitals, 209–308 samples)
• NDC 64208-2510-02 — Albumin 5% solution, 250 mL vialAI (121 hospitals, 56–308 samples)
• NDC 00767-2000-00 — HYDRALAZINE 20MG/ML 1ML (7 hospitals, 155–308 samples)
• NDC 13533-0692-71 — Albumin 25% intravenous solution, 25 g per 100 mLAI (62 hospitals, 65–308 samples)
• NDC 72266-0251-10 — Calcitriol 1 mcg/mL injection solutionAI (258 hospitals, 299–308 samples)
• NDC 409610219 — Furosemide injection 10 mg/mLAI (62 hospitals, 56–308 samples)
• NDC 409729511 — Potassium phosphate intravenous solutionAI (55 hospitals, 200–308 samples)
• NDC 63323026967A — INJECTION, PROPOFOL, 10 MG (1 hospital, 236–308 samples)
• NDC 63323026937A — INJECTION, PROPOFOL, 10 MG (1 hospital, 236–308 samples)
• NDC 51224-0022-06 — Azithromycin 250 mg tabletsAI (63 hospitals, 99–306 samples)
• NDC 67457-0847-44 — Trastuzumab-dkst (Ogivri) 420 mg IV infusion drugAI (228 hospitals, 171–306 samples)
• NDC 270044540 — Oral contrast solution for imaging (diatrizoate, 120 mL bottle)AI (147 hospitals, 171–306 samples)
• NDC 14789-0116-05 — Erythromycin lactobionate 500 mg IV injectionAI (320 hospitals, 297–306 samples)
• NDC 00186-0863-54 — Ropivacaine hydrochloride injectionAI (13 hospitals, 63–306 samples)
• NDC 00641-6076-10 — Neostigmine injection, 0.5 mg/mL, 10 mL vialAI (27 hospitals, 216–306 samples)
• NDC 13533-0645-24 — Immune globulin 10% IV Sol 200 mL (8 hospitals, 270–306 samples)
• NDC 70700-0171-23 — Neostigmine injection, 0.5 mg in 10 mL vialAI (18 hospitals, 216–306 samples)
• NDC 76014-0002-10 — Neostigmine injection 0.5 mg/mL, 10 mL vialAI (57 hospitals, 216–306 samples)
• NDC 00019-1333-61 — Iodinated contrast dye for intravenous injectionAI (13 hospitals, 297–306 samples)
• NDC 00409956610_2 — CEFEPIME 1 GRAM SOLUTION FOR INJECTION (8 hospitals, 288–306 samples)
• NDC 70092-1147-03 — Potassium chloride and lidocaine IV piggybackAI (25 hospitals, 296–305 samples)
• NDC 85920-0000-00 — POTASSIUM CHLORIDE 10 MEQ-LIDOCAINE 10 MG IN NS 100 ML (7 hospitals, 296–305 samples)
• NDC 55150-0329-25 — Medroxyprogesterone 150 mg/mL injectionAI (125 hospitals, 98–305 samples)
• NDC 00904-7009-06 — Buprenorphine and naloxone sublingual tabletAI (139 hospitals, 215–305 samples)
• NDC 407141353 — Iohexol Inj 300 MG/ML (3 hospitals, 269–305 samples)
• NDC 407141445 — Iohexol IV Soln 350 MG/ML (2 hospitals, 269–305 samples)
• NDC 407141485 — Iohexol IV Soln 350 MG/ML (2 hospitals, 269–305 samples)
• NDC 00409-1162-09 — Bupivacaine local anesthetic injection, 0.5% preservative-freeAI (157 hospitals, 44–305 samples)
• NDC 338171540 — Magnesium sulfate IV infusion in waterAI (34 hospitals, 161–305 samples)
• NDC 16729-0094-01 — Mycophenolate mofetil 250 mg capsulesAI (555 hospitals, 151–304 samples)
• NDC 70710-1478-01 — Fomepizole intravenous solution, 1.5 mL vialAI (780 hospitals, 268–304 samples)
• NDC 00143-9248-01 — Dexrazoxane injection for intravenous useAI (234 hospitals, 268–304 samples)
• NDC 62144-5510-05 — Hypromellose preservative-free artificial tear eye dropsAI (71 hospitals, 106–304 samples)
• NDC 47426-0303-01 — Zynrelef bupivacaine and meloxicam extended-release solutionAI (291 hospitals, 88–304 samples)
• NDC 00409-8300-20 — Bivalirudin injection, 250 mg vialAI (114 hospitals, 61–304 samples)